Krystal Biotech to Present at Goldman Sachs 43rd Annual Global Healthcare Conference
Krystal Biotech (NASDAQ: KRYS) announced its participation in the Goldman Sachs 43rd Annual Global Healthcare Conference scheduled for June 15, 2022. The company will be represented by Chairman and CEO Krish Krishnan in a session at 10:40 am PDT. Investors can access a live webcast of the presentation on the company’s website. Krystal Biotech is focused on developing innovative redosable gene therapies for serious conditions, particularly in skin and lung diseases.
- None.
- None.
PITTSBURGH, June 07, 2022 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), the leader in redosable gene therapy, announced today that the Company will participate in the Goldman Sachs 43rd Annual Global Healthcare Conference in Rancho Palos Verdes, California.
Krish Krishnan, Chairman and Chief Executive Officer, will represent the Company in a session scheduled at 10:40 am PDT on Wednesday, June 15.
A live webcast of the presentation will be available here and on the Investor section of the Company’s website.
About Krystal Biotech, Inc.
Krystal Biotech, Inc. (NASDAQ: KRYS) is a pivotal-stage gene therapy company leveraging its proprietary, redosable gene therapy platform and in-house manufacturing capabilities to develop life-changing medicines for patients with serious diseases, including rare diseases in skin, lung, and other areas. For more information please visit http://www.krystalbio.com, and follow @KrystalBiotech on LinkedIn and Twitter.
CONTACTS:
Investors and Media:
Meg Dodge
Krystal Biotech
mdodge@krystalbio.com
Source: Krystal Biotech, Inc.
FAQ
When will Krystal Biotech participate in the Goldman Sachs Healthcare Conference?
Who is speaking at the Goldman Sachs Conference for Krystal Biotech?
What time is Krystal Biotech's presentation at the conference?
How can I watch Krystal Biotech's presentation at the conference?
What is Krystal Biotech's focus in gene therapy?
